Stay informed with the latest updates for the inheritable blood disorders community. Medical First Sickle Cell Patient to Receive Gene Therapy Featured in NYT May 10, 2024 Medical FDA Approves Second Hemophilia B Gene Therapy ProductApr 30, 2024 Medical NBDF Announces New Treatment Recommendations for Bleeding DisordersApr 24, 2024 Medical Take the HTC Patient Satisfaction SurveyApr 15, 2024 Medical Intellia Therapeutics Withdraws from Hemophilia B…Apr 4, 2024 Medical Rebinyn Supplies Restored in 3,000 IU Vial SizeMar 27, 2024 Medical Hemophilia B Therapy FDA Approved for Expanded Indication Mar 26, 2024 Medical (Video) Celebrating Nurses in Bleeding Disorders Care Mar 19, 2024 Medical New Training Available to Early Career HematologistsMar 14, 2024 Medical Von Willebrand Emergency Care Manual Now Available in SpanishFeb 28, 2024 Medical FDA Approves Therapy for Rare Disorder Affecting Red Blood CellsFeb 5, 2024 Medical Novo Nordisk Experiencing Shortage of Rebinyn 3,000 IU VialsFeb 2, 2024 Medical Patient Receives First Hemophilia A Gene Therapy Outside a Clinical Trial…Jan 12, 2024 Medical Yale Researchers Explore the Possibilities of von Willebrand Factor Dec 15, 2023 Medical FDA Approves Pair of Cell-Based Gene Therapies for Sickle Cell DiseaseDec 12, 2023 Pagination First page Previous page Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page